Parallax Volatility Advisers, L.P. Enanta Pharmaceuticals Inc Put Options Transaction History

Parallax Volatility Advisers, L.P.

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q2 2019 Aug 14, 2019	SELL	$81.3 - $97.35 $1.02 Million - $1.22 Million	-12,500 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$69.08 - $105.66 $863,500 - $1.32 Million	12,500 New	12,500 $1.19 Million

110

21.2M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $115M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.